Faculty

Sascha Dublin

Affiliate Professor, Epidemiology

206-287-2870

Education

PhD Epidemiology, University of Washington, 1999
MD University of Washington, 2001

Contact

206-287-2870

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Research Interests

Dr. Dublin’s research interests include pharmacoepidemiology, pregnancy outcomes and perinatal epidemiology; aging; and cardiovascular epidemiology. Her work uses real-world health care data from Group Health and many other sources to better understand the safety and effectiveness of medications and other medical interventions.  She often focuses on the impact of interventions in vulnerable populations, particularly pregnant women and older adults. She also has interest and expertise in using novel statistical and epidemiologic methods to answer real-world questions, such as the use of two-phase study designs to reduce bias and Natural Language Processing  to extract information from electronic medical records (EMRs).  She is the Group Health site Principal Investigator for the Medication Exposures in Pregnancy Risk Evaluation Program (MEPREP), a multisite collaboration that has developed data sets including 1.2 million pregnancies across 11 health plans to examine medication safety in pregnant women.

Recent Publications (PubMed)

Patterns of Drug and Polydrug Detection in Drivers Suspected of Driving Under the Influence of an Intoxicant in Ireland 2019-2020: A Latent Class Analysis.
(2026 Jan)
Drug Alcohol Rev 45(1): e70087
Durand L, O'Kane A, Maguire R, Cusack D, Keenan E, Cousins G

Legal implications of AI standard of care integration on patients' informed consent: lessons from surgery.
(2025 Dec 13)
NPJ Digit Med
Duffourc MN, Cahill RA

The complexity of outcome measure selection within multiple long-term condition research: an analysis of exercise-based rehabilitation trials.
(2025 Dec 13)
Trials
Manifield JR, Evans RA, Smith SM, Holland AE, Skou ST, Taylor RS, Singh SJ

Responses to active stand test predict 12-year incident cardiovascular disease and mortality.
(2025 Dec 13)
Commun Med (Lond)
Hernández B, Dyer AH, McCrory C, Newman L, Ward M, Finucane C, Kenny RA

Correction: ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.
(2025 Dec 13)
BMC Med 23(1): 682
Charmsaz S, Doherty B, Cocchiglia S, Varešlija D, Marino A, Cosgrove N, Marques R, Priedigkeit N, Purcell S, Bane F, Bolger J, Byrne C, O'Halloran PJ, Brett F, Sheehan K, Brennan K, Hopkins AM, Keelan S, Jagust P, Madden S, Martinelli C, Battaglini M, Oesterreich S, Lee AV, Ciofani G, Hill ADK, Young LS

Show complete publication list

In the News